Chugai Pharmaceutical Co., Ltd. (CHGCY)
OTCMKTS · Delayed Price · Currency is USD
20.64
+0.16 (0.78%)
Nov 21, 2024, 4:00 PM EST

Chugai Pharmaceutical Statistics

Total Valuation

Chugai Pharmaceutical has a market cap or net worth of 66.76 billion. The enterprise value is 61.29 billion.

Market Cap 66.76B
Enterprise Value 61.29B

Important Dates

The last earnings date was Friday, October 25, 2024.

Earnings Date Oct 25, 2024
Ex-Dividend Date n/a

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) +0.01%
Shares Change (QoQ) +0.01%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 639.51M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 16.56, with an EV/FCF ratio of 25.01.

EV / Earnings 22.69
EV / Sales 8.29
EV / EBITDA 16.56
EV / EBIT 17.54
EV / FCF 25.01

Financial Position

The company has a current ratio of 5.89

Current Ratio 5.89
Quick Ratio 4.67
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage 67,522.21

Financial Efficiency

Return on equity (ROE) is 23.20% and return on invested capital (ROIC) is 20.24%.

Return on Equity (ROE) 23.20%
Return on Assets (ROA) 17.37%
Return on Capital (ROIC) 20.24%
Revenue Per Employee 1.05M
Profits Per Employee 355,215
Employee Count 7,604
Asset Turnover 0.59
Inventory Turnover 1.22

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +25.78% in the last 52 weeks. The beta is 0.53, so Chugai Pharmaceutical's price volatility has been lower than the market average.

Beta (5Y) 0.53
52-Week Price Change +25.78%
50-Day Moving Average 23.54
200-Day Moving Average 20.07
Relative Strength Index (RSI) 31.18
Average Volume (20 Days) 119,920

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Chugai Pharmaceutical had revenue of 7.97 billion and earned 2.70 billion in profits. Earnings per share was 1.64.

Revenue 7.97B
Gross Profit 5.62B
Operating Income 3.77B
Pretax Income 3.77B
Net Income 2.70B
EBITDA 3.96B
EBIT 3.77B
Earnings Per Share (EPS) 1.64
Full Income Statement

Balance Sheet

Cash & Cash Equivalents 5.90B
Total Debt n/a
Net Cash 5.90B
Net Cash Per Share n/a
Equity (Book Value) 12.57B
Book Value Per Share 7.64
Working Capital 8.58B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.93 billion and capital expenditures -477.49 million, giving a free cash flow of 2.45 billion.

Operating Cash Flow 2.93B
Capital Expenditures -477.49M
Free Cash Flow 2.45B
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 70.48%, with operating and profit margins of 47.29% and 33.87%.

Gross Margin 70.48%
Operating Margin 47.29%
Pretax Margin 47.29%
Profit Margin 33.87%
EBITDA Margin 49.64%
EBIT Margin 47.29%
FCF Margin 30.73%

Dividends & Yields

Chugai Pharmaceutical does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio 34.45%
Buyback Yield -0.01%
Shareholder Yield -0.01%
Earnings Yield n/a
FCF Yield n/a

Stock Splits

The last stock split was on July 6, 2020. It was a forward split with a ratio of 12.

Last Split Date Jul 6, 2020
Split Type Forward
Split Ratio 12

Scores

Chugai Pharmaceutical has an Altman Z-Score of 23.76.

Altman Z-Score 23.76
Piotroski F-Score n/a